Screener
Carlsmed, Inc. CARL Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Carlsmed, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Carlsmed, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001794546-26-000016
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Sales and marketing | 11,920 | 7,869 | 22,217 | 14,608 |
| General and administrative | 7,618 | 3,342 | 13,844 | 6,808 |
| Total operating expenses | 25,578 | 15,371 | 47,279 | 28,726 |
| Loss from operations | (11,036) | (6,502) | (20,312) | (12,221) |
| Other income (expense): | ||||
| Interest expense | (313) | (363) | (624) | (720) |
| Interest income | 839 | 336 | 1,730 | 716 |
| Change in fair value of warrant liabilities | — | (237) | — | (270) |
Item 1. Financial Statements.
FAQ
- What is Carlsmed, Inc.'s operating income?
- Carlsmed, Inc. (CARL) reported operating income of -$11.04M in Q2 2026.
- How has Carlsmed, Inc.'s operating income changed year-over-year?
- Carlsmed, Inc.'s operating income decreased by 69.7% year-over-year, from -$6.5M to -$11.04M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Carlsmed, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude